Janney Montgomery Scott LLC Purchases 16,407 Shares of Astera Labs, Inc. $ALAB

Janney Montgomery Scott LLC boosted its position in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 483.7% in the 1st quarter, Holdings Channel reports. The institutional investor owned 19,799 shares of the company’s stock after purchasing an additional 16,407 shares during the period. Janney Montgomery Scott LLC’s holdings in Astera Labs were worth $2,170,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of ALAB. Reflection Asset Management bought a new stake in shares of Astera Labs in the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares in the last quarter. Hilltop National Bank grew its holdings in shares of Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the last quarter. Aventura Private Wealth LLC bought a new position in shares of Astera Labs during the 4th quarter valued at $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs in the 4th quarter worth $33,000. 60.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ALAB. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Bank of America raised their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Barclays lifted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Rothschild & Co Redburn assumed coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Finally, Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $265.75.

View Our Latest Analysis on ALAB

Astera Labs Stock Performance

Shares of ALAB stock opened at $393.16 on Thursday. Astera Labs, Inc. has a fifty-two week low of $88.18 and a fifty-two week high of $499.48. The firm has a market cap of $67.39 billion, a P/E ratio of 265.65, a P/E/G ratio of 4.39 and a beta of 3.66. The business’s 50 day moving average price is $326.75 and its 200-day moving average price is $211.47.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the company earned $0.33 earnings per share. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,164,441 shares of company stock valued at $526,198,280. 10.40% of the stock is currently owned by company insiders.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.